世界のC型肝炎ウイルス（HCV）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hepatitis C Virus (HCV) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2788 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、C型肝炎ウイルス（HCV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・C型肝炎ウイルス（HCV）の市場動向 ・企業の競争状況、市場シェア ・C型肝炎ウイルス（HCV）の種類別市場規模（治療薬、ワクチン） ・C型肝炎ウイルス（HCV）の用途別市場規模（病院、外来手術センター、診断センター） ・C型肝炎ウイルス（HCV）の北米市場規模2016-2027（アメリカ、カナダ） ・C型肝炎ウイルス（HCV）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・C型肝炎ウイルス（HCV）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・C型肝炎ウイルス（HCV）の中南米市場規模2016-2027（メキシコ、ブラジル） ・C型肝炎ウイルス（HCV）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Genentech、Vertex、Janssen and Medivir、F. Hoffmann-La Roche、Bristol Myers Squibb、AbbVie、Gilead Sciences） ・結論

Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.

Market Analysis and Insights: Global Hepatitis C Virus (HCV) Market
The global Hepatitis C Virus (HCV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis C Virus (HCV) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis C Virus (HCV) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis C Virus (HCV) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis C Virus (HCV) market.

Global Hepatitis C Virus (HCV) Scope and Market Size
Hepatitis C Virus (HCV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Virus (HCV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Therapeutics
Vaccine

Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Genentech
Vertex
Janssen and Medivir
F. Hoffmann-La Roche
Bristol Myers Squibb
AbbVie
Gilead Sciences

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Therapeutics
1.2.3 Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis C Virus (HCV) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Market Perspective (2016-2027)
2.2 Hepatitis C Virus (HCV) Growth Trends by Regions
2.2.1 Hepatitis C Virus (HCV) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis C Virus (HCV) Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis C Virus (HCV) Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis C Virus (HCV) Industry Dynamic
2.3.1 Hepatitis C Virus (HCV) Market Trends
2.3.2 Hepatitis C Virus (HCV) Market Drivers
2.3.3 Hepatitis C Virus (HCV) Market Challenges
2.3.4 Hepatitis C Virus (HCV) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Players by Revenue
3.1.1 Global Top Hepatitis C Virus (HCV) Players by Revenue (2016-2021)
3.1.2 Global Hepatitis C Virus (HCV) Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis C Virus (HCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Revenue
3.4 Global Hepatitis C Virus (HCV) Market Concentration Ratio
3.4.1 Global Hepatitis C Virus (HCV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Revenue in 2020
3.5 Hepatitis C Virus (HCV) Key Players Head office and Area Served
3.6 Key Players Hepatitis C Virus (HCV) Product Solution and Service
3.7 Date of Enter into Hepatitis C Virus (HCV) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis C Virus (HCV) Breakdown Data by Type
4.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2022-2027)

5 Hepatitis C Virus (HCV) Breakdown Data by Application
5.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis C Virus (HCV) Market Size (2016-2027)
6.2 North America Hepatitis C Virus (HCV) Market Size by Type
6.2.1 North America Hepatitis C Virus (HCV) Market Size by Type (2016-2021)
6.2.2 North America Hepatitis C Virus (HCV) Market Size by Type (2022-2027)
6.2.3 North America Hepatitis C Virus (HCV) Market Size by Type (2016-2027)
6.3 North America Hepatitis C Virus (HCV) Market Size by Application
6.3.1 North America Hepatitis C Virus (HCV) Market Size by Application (2016-2021)
6.3.2 North America Hepatitis C Virus (HCV) Market Size by Application (2022-2027)
6.3.3 North America Hepatitis C Virus (HCV) Market Size by Application (2016-2027)
6.4 North America Hepatitis C Virus (HCV) Market Size by Country
6.4.1 North America Hepatitis C Virus (HCV) Market Size by Country (2016-2021)
6.4.2 North America Hepatitis C Virus (HCV) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hepatitis C Virus (HCV) Market Size (2016-2027)
7.2 Europe Hepatitis C Virus (HCV) Market Size by Type
7.2.1 Europe Hepatitis C Virus (HCV) Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis C Virus (HCV) Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis C Virus (HCV) Market Size by Type (2016-2027)
7.3 Europe Hepatitis C Virus (HCV) Market Size by Application
7.3.1 Europe Hepatitis C Virus (HCV) Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis C Virus (HCV) Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis C Virus (HCV) Market Size by Application (2016-2027)
7.4 Europe Hepatitis C Virus (HCV) Market Size by Country
7.4.1 Europe Hepatitis C Virus (HCV) Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis C Virus (HCV) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Market Size (2016-2027)
9.2 Latin America Hepatitis C Virus (HCV) Market Size by Type
9.2.1 Latin America Hepatitis C Virus (HCV) Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis C Virus (HCV) Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis C Virus (HCV) Market Size by Type (2016-2027)
9.3 Latin America Hepatitis C Virus (HCV) Market Size by Application
9.3.1 Latin America Hepatitis C Virus (HCV) Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis C Virus (HCV) Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis C Virus (HCV) Market Size by Application (2016-2027)
9.4 Latin America Hepatitis C Virus (HCV) Market Size by Country
9.4.1 Latin America Hepatitis C Virus (HCV) Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis C Virus (HCV) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Hepatitis C Virus (HCV) Introduction
11.1.4 Merck Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Genentech
11.2.1 Genentech Company Details
11.2.2 Genentech Business Overview
11.2.3 Genentech Hepatitis C Virus (HCV) Introduction
11.2.4 Genentech Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.2.5 Genentech Recent Development
11.3 Vertex
11.3.1 Vertex Company Details
11.3.2 Vertex Business Overview
11.3.3 Vertex Hepatitis C Virus (HCV) Introduction
11.3.4 Vertex Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.3.5 Vertex Recent Development
11.4 Janssen and Medivir
11.4.1 Janssen and Medivir Company Details
11.4.2 Janssen and Medivir Business Overview
11.4.3 Janssen and Medivir Hepatitis C Virus (HCV) Introduction
11.4.4 Janssen and Medivir Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.4.5 Janssen and Medivir Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Hepatitis C Virus (HCV) Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Hepatitis C Virus (HCV) Introduction
11.6.4 Bristol Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.6.5 Bristol Myers Squibb Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Hepatitis C Virus (HCV) Introduction
11.7.4 AbbVie Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Hepatitis C Virus (HCV) Introduction
11.8.4 Gilead Sciences Revenue in Hepatitis C Virus (HCV) Business (2016-2021)
11.8.5 Gilead Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Therapeutics
Table 3. Key Players of Vaccine
Table 4. Global Hepatitis C Virus (HCV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hepatitis C Virus (HCV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis C Virus (HCV) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hepatitis C Virus (HCV) Market Share by Regions (2016-2021)
Table 8. Global Hepatitis C Virus (HCV) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hepatitis C Virus (HCV) Market Share by Regions (2022-2027)
Table 10. Hepatitis C Virus (HCV) Market Trends
Table 11. Hepatitis C Virus (HCV) Market Drivers
Table 12. Hepatitis C Virus (HCV) Market Challenges
Table 13. Hepatitis C Virus (HCV) Market Restraints
Table 14. Global Hepatitis C Virus (HCV) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hepatitis C Virus (HCV) Market Share by Players (2016-2021)
Table 16. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) as of 2020)
Table 17. Ranking of Global Top Hepatitis C Virus (HCV) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hepatitis C Virus (HCV) Product Solution and Service
Table 21. Date of Enter into Hepatitis C Virus (HCV) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2016-2021)
Table 25. Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hepatitis C Virus (HCV) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hepatitis C Virus (HCV) Revenue Market Share by Application (2016-2021)
Table 29. Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hepatitis C Virus (HCV) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Hepatitis C Virus (HCV) Product
Table 64. Merck Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Genentech Company Details
Table 67. Genentech Business Overview
Table 68. Genentech Hepatitis C Virus (HCV) Product
Table 69. Genentech Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 70. Genentech Recent Development
Table 71. Vertex Company Details
Table 72. Vertex Business Overview
Table 73. Vertex Hepatitis C Virus (HCV) Product
Table 74. Vertex Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 75. Vertex Recent Development
Table 76. Janssen and Medivir Company Details
Table 77. Janssen and Medivir Business Overview
Table 78. Janssen and Medivir Hepatitis C Virus (HCV) Product
Table 79. Janssen and Medivir Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 80. Janssen and Medivir Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Hepatitis C Virus (HCV) Product
Table 84. F. Hoffmann-La Roche Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Bristol Myers Squibb Company Details
Table 87. Bristol Myers Squibb Business Overview
Table 88. Bristol Myers Squibb Hepatitis C Virus (HCV) Product
Table 89. Bristol Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 90. Bristol Myers Squibb Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Hepatitis C Virus (HCV) Product
Table 94. AbbVie Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 95. AbbVie Recent Development
Table 96. Gilead Sciences Company Details
Table 97. Gilead Sciences Business Overview
Table 98. Gilead Sciences Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million)
Table 99. Gilead Sciences Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Virus (HCV) Market Share by Type: 2020 VS 2027
Figure 2. Therapeutics Features
Figure 3. Vaccine Features
Figure 4. Global Hepatitis C Virus (HCV) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Hepatitis C Virus (HCV) Report Years Considered
Figure 9. Global Hepatitis C Virus (HCV) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hepatitis C Virus (HCV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hepatitis C Virus (HCV) Market Share by Regions: 2020 VS 2027
Figure 12. Global Hepatitis C Virus (HCV) Market Share by Regions (2022-2027)
Figure 13. Global Hepatitis C Virus (HCV) Market Share by Players in 2020
Figure 14. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Revenue in 2020
Figure 16. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2016-2021)
Figure 17. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2022-2027)
Figure 18. North America Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hepatitis C Virus (HCV) Market Share by Type (2016-2027)
Figure 20. North America Hepatitis C Virus (HCV) Market Share by Application (2016-2027)
Figure 21. North America Hepatitis C Virus (HCV) Market Share by Country (2016-2027)
Figure 22. United States Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hepatitis C Virus (HCV) Market Share by Type (2016-2027)
Figure 26. Europe Hepatitis C Virus (HCV) Market Share by Application (2016-2027)
Figure 27. Europe Hepatitis C Virus (HCV) Market Share by Country (2016-2027)
Figure 28. Germany Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Region (2016-2027)
Figure 38. China Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hepatitis C Virus (HCV) Market Share by Type (2016-2027)
Figure 46. Latin America Hepatitis C Virus (HCV) Market Share by Application (2016-2027)
Figure 47. Latin America Hepatitis C Virus (HCV) Market Share by Country (2016-2027)
Figure 48. Mexico Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Country (2016-2027)
Figure 54. Turkey Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 58. Genentech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 59. Vertex Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 60. Janssen and Medivir Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 62. Bristol Myers Squibb Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 64. Gilead Sciences Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---